MARKET

PODD

PODD

Insulet Corp
NASDAQ
282.92
-1.32
-0.46%
After Hours: 282.75 -0.17 -0.06% 17:44 01/02 EST
OPEN
285.46
PREV CLOSE
284.24
HIGH
286.52
LOW
280.18
VOLUME
456.79K
TURNOVER
--
52 WEEK HIGH
354.88
52 WEEK LOW
230.05
MARKET CAP
19.90B
P/E (TTM)
82.08
1D
5D
1M
3M
1Y
5Y
1D
Is This the Right Time to Add PBH Stock to Your Portfolio?
NASDAQ · 20h ago
2 Mid-Cap Stocks to Own for Decades and 1 That Underwhelm
Barchart · 12/31/2025 10:00
Best Growth Stocks to Buy for December 31st
NASDAQ · 12/31/2025 09:54
Should Myriad Genetics Stock Stay in Your Portfolio Right Now?
NASDAQ · 12/30/2025 13:06
Reasons to Add Cooper Companies Stock to Your Portfolio Now
NASDAQ · 12/30/2025 12:33
Should You Continue to Hold EXAS Stock in Your Portfolio Now?
NASDAQ · 12/30/2025 12:32
Weekly Report: what happened at PODD last week (1222-1226)?
Weekly Report · 12/29/2025 09:44
Notable healthcare headlines for the week: J&J, Pfizer, and Novo Nordisk in focus
Seeking Alpha · 12/28/2025 14:05
More
About PODD
Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.

Webull offers Insulet Corp stock information, including NASDAQ: PODD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PODD stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PODD stock methods without spending real money on the virtual paper trading platform.